It was an honor to share the stage with colleagues from Ireland, India, Japan, Austria, and South Africa discussing workforce challenges, resource limitations, and expanding access to care globally in our #GlobalPolicyandPartnerships session

Reflecting on a data-packed
@iaslc.bsky.social #WCL25 with non-clinical panels on Narrowing Disparities in Effective Management of Lung Cancer on the Global Scale and the
@who.int
#IntegratedLungHealthResolution stand out most--time to bring these findings home!

The MARIPOSA effect 🦋
‼️Awaited OS data for #Amivantamab + lazertinib vs osimertinib in 1L EGFRm advanced #lungcancer presented at #ELCC25

🎯OS HR 0.75 (95%CI: 0.61-0.92)
🎉> 1 yr mOS advantage
🚫no crossover allowed, ⬆️intracranial activity
⬇️toxicity over time w prophylactic mgmt (skin)
#lcsm

Join us today at noon EST for free #PatientEducation to discuss all things new in the management of Colorectal Cancers @BHCancerCare @BaptistHealthSF @MiamiCancerInst

#CRCSM #PatientEducation

3 points of progress vs pancreatic cancer!
1. Neoantigen vaccines
www.nature.com/articles/s41...
2. KRAS drugs
www.wsj.com/health/healt...
3. Early diagnosis www.science.org/doi/10.1126/...

First lecture as faculty yesterday to the @FAUCollegeofMedicine + @WPBVAHCS Pulmonology team. 🫁 cancers are still a team sport in 2025 and beyond! @iaslc.bsky.social @ascocancer.bsky.social @FLASCO_ORG @BHCancerCare